Study of ADI-PEG 20 in Patients With Advanced Melanoma
NCT00520299
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Melanoma
Skin Cancer
Neoplasm
Interventions
DRUG:
ADI PEG 20
Sponsor
Ludwig Institute for Cancer Research
Collaborators
[object Object]
[object Object]